Bayer Launches Esplanade Herbicide

Bayer introduces Esplanade Herbicide into the Vegetation Management market.

Esplanade herbicide from Bayer



Esplanade Herbicide is a pre-emergent herbicide that offers long-lasting control of over 30 species of annual grasses, broadleaves, and sedges at rates many times lower than previous standards such as pendimethalin and Diuron. Esplanade is used primarily in vegetation management (VM) applications such as railroads, utility substations, and roadside rights-of-way, among others. Esplanade may also be used pre-plant and post-plant for weed control in forestry plantations.

Esplanade contains the active ingredient indaziflam, which is one of the most effective and long-lasting pre-emergence solutions available.

Please complete the contact form here if you are interested in purchasing Esplanade herbicide, or if you are interested in becoming a distributor/agent for Esplanade herbicide.



About Bayer in Australia

Bayer is a world class innovation company with more than 150 years’ history and core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit humans, animals and plants.  It has operated in Australia since 1925 and has a long term commitment to the health of Australians, the agricultural industry and the welfare of animals, large and small.  In Australia, Bayer currently employs almost 900 people across the country and is dedicated to servicing the needs of rural Australia and the local community. Bayer is deeply committed to research and development and has a strong tradition of innovation with the development and commercialisation of over 5,000 products and services. The company’s focus on people, partnerships and innovation underpins all aspects of its operations, consistent with its mission, “Bayer: Science For A Better Life.”



Paul Crack

National Sales Manager (VM)

(m) 0438 991 907


For further information on Glyphosate: (Retrieved 9 May 2019)




Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.